Oral Rigosertib in Low Risk MDS Patients Refractory to ESAs
Clinical trial NCT01904682 · COMPLETED
Trial details
- NCT number
- NCT01904682
- Sponsor
- Traws Pharma, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-01
- Primary completion
- 2020-12-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.